BioMarin Pharmaceutical Inc. (BMRN)

NMS – Real Time Price. Currency in USD

52.88

+0.30 (0.57%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

3.24B

2.84B

2.42B

2.05B

Cost of goods sold

-737M

-623M

-577M

-546M

Gross Profit

2.51B

2.22B

1.84B

1.50B

Operating expenses (excl. COGS)

-1.61B

-1.69B

-1.65B

-1.49B

Operating Income

892M

530M

194M

Non-operating income, total

-410M

12M

-6M

141M

Pretax income

482M

542M

189M

150M

Equity in earnings

Taxes

-134M

-115M

-21M

-8M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

349M

427M

168M

142M

BioMarin Pharmaceutical Inc. (BMRN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioMarin Pharmaceutical Inc. (BMRN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

BioMarin Pharmaceutical Inc. (BMRN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioMarin Pharmaceutical Inc. (BMRN)

Income Statement (Annual)

Income Statement (Annual)